Left Menu
Development News Edition

Science News Roundup: Half of lymphoma patients alive three years after Gilead cell therapy treatment


Science News Roundup: Half of lymphoma patients alive three years after Gilead cell therapy treatment
Image Credit: Storyblocks

Following is a summary of current science news briefs.

Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial. The company said it will apply for U.S. approval for the treatment for a type of advanced blood cancer by the end of the year.

Half of lymphoma patients alive three years after Gilead cell therapy treatment: study

Nearly half of lymphoma patients treated with Gilead Sciences Inc's Yescarta were alive at least three years after a one-time infusion of the CAR-T cell therapy, according to data presented on Saturday. Out of 101 patients teated with Yescarta for an aggressive blood cancer known as refractory large B-cell lymphoma in the study, 47 were still alive at least three years later, the data presented at the American Society of Hematology meeting in Orlando showed.

(With inputs from agencies.)

Download The Devdiscourse News App for Latest News.


TRENDING

OPINION/BLOG/INTERVIEW

Future of Food: Technology fostering the road to global food security

Technological innovation can help address most of the pressing issues facing the world today including food security by enhancing productivity, improving financial services, managing resources, addressing environmental concerns, etc....

Conspiracy theories on COVID 19: Legislators, Scientists, and Journalists all joined the Caravan

Conspiracy theories are not new for virus epidemics. There have been conspiracy theories on HIV-AIDS, Polio Vaccines, Ebola Virus, and several other diseases as well. However, what makes the 2019 Novel Coronavirus different from others is ...

Now it’s a war, Uganda deploys army to combat locust swarms

Its for the first time after 1986, the locust swarms have attacked Uganda twice in a season. With the increasing number of countries of Africa under attack by locust swarms, the problem seems to have taken a regional paradigm. Its very diff...

Top 10 Fake News, Myths and Realities on 2019 Novel Coronavirus COVID 19

With nearly 1500 deaths by January 14 and around 65,000 infections in China, the Novel Coronavirus 2019 has become one of the worst health epidemics of the 21st Century. However, 8,573 people have been cured but the rumor mongers are a...

Videos

Latest News

Quarantine on cruise ship may have increased number of onboard coronavirus cases: Study

Quarantining the cruise ship Diamond Princess, some of whose passengers were infected with the novel coronavirus, may have resulted in more cases of the viral infection than if they would have disembarked immediately, according to a study T...

Nirbhaya case: Convict Akshay Singh moves Delhi court seeking stay on execution of death warrants for all four convicts, scheduled for March 3. PTI UK SMNSMN

Nirbhaya case Convict Akshay Singh moves Delhi court seeking stay on execution of death warrants for all four convicts, scheduled for March 3. PTI UK SMNSMN...

Iran dismisses 'rumours' as virus deaths jump to 43

Iran Saturday dismissed as rumors a report that coronavirus has killed more than 200 people in the country, one of the hardest hit by the disease, with senior officials among those infected Since it announced its first coronavirus deaths, I...

Nirbhaya convict files fresh mercy petition before President, claiming previous was incomplete

Akshay Thakur, one of the death row convicts in the Nirbhaya gangrape and murder case, on Saturday moved complete mercy petition, claiming that the petition filed by him earlier, and which was dismissed by President Ram Nath Kovind, was inc...

Give Feedback